CMA1 and diabetic kidney disease: The oral administration of the chymase inhibitor TEI-F00806 in a model of streptozotocin-induced diabetes in hamsters (which induces diabetic nephropathy associated with renal chymase expression) was shown to ameliorate proteinuria and several other parameters of pathology, including the normalization of Ang II levels [103].